Your browser doesn't support javascript.
loading
Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study.
Liu, Lei; Zhang, Xin; Zhang, Li; Liu, Ying; Zhang, Hong Ping; Zhao, Shu Zhen; Zhang, Jie; Zhang, Wei Jie; Wang, Fang; Wang, Lei; Zhou, Anny Xiaobo; Li, Wei Min; Wang, Gang; Gibson, Peter Gerard.
Affiliation
  • Liu L; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan Universi
  • Zhang X; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan Universi
  • Zhang L; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan Universi
  • Liu Y; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan Universi
  • Zhang HP; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
  • Zhao SZ; Outpatient Department, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
  • Zhang J; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Jilin University, Changchun 130041, Jilin, China.
  • Zhang WJ; Department of Respiratory Disease, Jilin Province People's Hospital, Changchun, 130021, Jilin, China.
  • Wang F; Department of Pathogen Biology, Basic Medical College, Jilin University, Changchun, 130021, Jilin, China.
  • Wang L; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
  • Zhou AX; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Li WM; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. Electronic address: weimin003@163.com.
  • Wang G; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichu
  • Gibson PG; Priority Research Centre for Healthy Lungs and Centre of Excellence in Severe Asthma, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.
Respir Med ; 200: 106924, 2022.
Article de En | MEDLINE | ID: mdl-35772189

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Asthme / Obstruction des voies aériennes Type d'étude: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Respir Med Année: 2022 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Asthme / Obstruction des voies aériennes Type d'étude: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Respir Med Année: 2022 Type de document: Article